
Gracell Biotechnologies Inc.
GRCLNASDAQHealthcare
$10.25
+$0.01(+0.05%)
Market Cap$197973420
P/E Ratio—
52W High$10.435
52W Low$1.4
Gracell Biotechnologies Inc.(GRCL)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · GRCL · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.49B | $0.33B | $0.17B | $0.12B | $0.05B |
| G&A Expenses | $0.14B | $0.14B | $0.05B | $0.03B | $0.01B |
| Total Operating Expenses | $0.62B | $0.46B | $0.21B | $0.15B | $0.06B |
| Operating Income | ($0.62B) | ($0.46B) | ($0.21B) | ($0.15B) | ($0.06B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.61B) | ($0.45B) | ($0.21B) | ($0.14B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.01B) | ($0.01B) | $0.00B |
| Net Income | ($0.61B) | ($0.47B) | ($0.20B) | ($0.13B) | ($0.06B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-44.85 | $-35.40 | $-15.05 | $-33.35 | $-15.35 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B |
| EBITDA | ($0.57B) | ($0.39B) | ($0.20B) | ($0.14B) | ($0.06B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CNY · B
深入了解Gracell Biotechnologies Inc.
关于Gracell Biotechnologies Inc.(GRCL)损益表
Gracell Biotechnologies Inc.(GRCL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,GRCL实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.61B)(净利率—)。
常见问题
GRCL · 4 问Gracell Biotechnologies Inc.(GRCL)2022财年营收为$0.00B,同比down100.0%。
GRCL revenueGRCL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09